Sterling Biotech rose 5.31% to Rs 6.55 at 14:54 IST on BSE after the company reported net loss of Rs 90.35 crore in Q1 March 2015, lower than net loss of Rs 103.33 crore in Q1 March 2014.
The Q4 result was announced after market hours on Friday, 15 May 2015.
Meanwhile, the S&P BSE Sensex was up 262.73 points or 0.96% at 27,574.43.
On BSE, so far 1.46 lakh shares were traded in the counter as against average daily volume of 1.52 lakh shares in the past one quarter.
The stock hit a high of Rs 6.60 and a low of Rs 6.01 so far during the day. The stock had hit a 52-week high of Rs 19.45 on 2 July 2014. The stock had hit a 52-week low of Rs 4.10 on 27 March 2015.
The stock had underperformed the market over the past one month till 15 May 2015, sliding 5.9% compared with Sensex's 5.12% fall. The scrip had, however, outperformed the market in past one quarter, jumping 6.87% as against Sensex's 6.09% fall.
More From This Section
The small-cap company has equity capital of Rs 27.20 crore. Face value per share is Re 1.
Sterling Biotech's net sales declined 46.5% to Rs 100.63 crore in Q1 March 2015 over Q1 March 2014.
Sterling Biotech's core business is the manufacture of gelatin for pharmaceutical and edible uses.
Powered by Capital Market - Live News